STOCK TITAN

TD Bank subsidiary reports 2.62M UroGen shares (URGN) — 5.4%

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

UroGen Pharma Ltd. holdings disclosure: The Toronto-Dominion Bank and TD Securities Inc. report beneficial ownership of 2,618,020 shares of UroGen ordinary shares, representing 5.4% of the class. The filing states TD Bank holds sole voting and dispositive power over 2,616,714 shares and TDSI holds sole voting and dispositive power over 1,306 shares. The statement is a joint Schedule 13G filing and includes a signed joint filing agreement dated May 15, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large institutional holder reports passive ownership just above 5% threshold.

TD Bank and its broker affiliate TD Securities Inc. report combined beneficial ownership of 2,618,020 shares, or 5.4%. The filing lists exact vote and disposition powers: TD Bank 2,616,714, TDSI 1,306.

The disclosure signals a material, reportable stake under federal rules; subsequent trading by these entities or related parties would be disclosed in future filings.

Joint Schedule 13G clarifies ownership and disclaims group control.

The filing includes a joint filing agreement and an explicit disclaimer that the reporting persons are not acting as a group for Section 13(d) purposes. It also states TD Bank may be deemed to hold an indirect interest in TDSI's shares due to ownership.

Material dependencies include any change in voting/dispositive power or increases above reporting thresholds, which would trigger different disclosure obligations.

Beneficial ownership 2,618,020 shares reported in Schedule 13G
Percent of class 5.4% percent of outstanding ordinary shares
TD Bank sole voting power 2,616,714 shares sole power to vote and dispose
TD Securities (TDSI) sole power 1,306 shares sole power to vote and dispose
Signature date May 15, 2026 joint filing agreement signed
Schedule 13G regulatory
"joint Schedule 13G filing and includes a signed joint filing agreement"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: 2,618,020"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power regulatory
"TD Bank has the sole power to vote or direct the vote of 2,616,714"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Section 13(d) regulatory
"shall not be construed as an admission ... acting together ... for the purposes of Section 13(d)"





M96088105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



The Toronto-Dominion Bank
Signature:Christina Petrou
Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
Date:05/15/2026
TD SECURITIES INC.
Signature:Greg Nowakowski
Name/Title:Greg Nowakowski / Chief Compliance Officer
Date:05/15/2026
Exhibit Information

Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the ordinary shares of UroGen Pharma Ltd. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: May 15, 2026 THE TORONTO-DOMINION BANK By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TD SECURITIES INC. By: /s/ Greg Nowakowski Title: Chief Compliance Officer

FAQ

What stake does TD Bank report in UroGen (URGN)?

TD Bank and TD Securities report combined beneficial ownership of 2,618,020 shares, representing 5.4%. The filing breaks out TD Bank's sole power over 2,616,714 shares and TDSI's sole power over 1,306 shares.

Does the Schedule 13G say TD Bank is acting as a group with others?

No; the filing includes a explicit statement that neither reporting person admits to acting together as a group under Section 13(d). A joint filing agreement is included and signed on May 15, 2026.

Who has voting and dispositive power over the reported shares?

The Toronto-Dominion Bank has sole voting and dispositive power over 2,616,714 shares and TD Securities Inc. has sole voting and dispositive power over 1,306 shares, as shown in the filing's ownership table.

Does TD Bank claim direct ownership of TDSI's shares?

TD Bank states it may be deemed to hold an indirect interest in TDSI's reported shares by virtue of ownership of TDSI, and it expressly disclaims ownership of those shares except to the extent of any pecuniary interest.

When was this Schedule 13G signed and filed?

The joint filing agreement and signatures in the excerpt are dated May 15, 2026, with the cover referencing an ownership snapshot as of 03/31/2026 in the header information.